Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid

Indian Journal of Biochemistry and Biophysics

Volumn 49, Issue 5, 2012, Pages 392-394

  Manivannan, Prabhu ^a   Siddaraju, Neelaiah ^a   Jatiya, Lakshmi ^b   Verma, Surendra Kumar ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b Aarupadai Veedu Medical College and Hospital   (India)

Author keywords

Follicular adenoma; Follicular carcinoma; Follicular variant of papillary thyroid carcinoma; Galectin 3; Immunohistochemistry

Indexed keywords

ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; GALECTIN 3;

ADENOMA; ARTICLE; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADENOMA; ANGIOGENIC PROTEINS; BIOLOGICAL MARKERS; GALECTIN 3; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 84924232174     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. LiVolsi V A & Baloch Z W (2004) Adv Anat Pathol 11, 279-287
2. Asa S L (2005) Endocrine Pathol 16, 295-309
3. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos A P, Orlandi F & Papotti M (2005) Endocr Relat Cancer 12, 305-317
4. Aron M, Kapila K & Verma K (2006) Indian J Pathol Microbiol 49, 376-380
5. Ishiwata T, Iino Y, Takei H, Oyama T & Morishita Y (1998) Oncol Rep 5, 1343-1348
6. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta K J & Raz A (2000) Am J Pathol 156, 899-909
7. Sprindzuk M (2010) J Clin Pathol Forensic Med 3, 16-34
8. Kim M J, Kim H J, Hong S J, Shong Y K & Gong G (2006) Acta Cytol 50, 28-34
9. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R & Larsson O. Thyroid Cancer Study Group (2001) Lancet 357, 1644-1650